Gen-AI Designed Enzymes for Pharmaceutical Innovation
Company research
Public company, workplace, funding, and market signals
Overview
Pando Bioscience is a Boston-area AI-driven synthetic biology company that engineers industrial-grade enzymes for pharma, diagnostics, and life-science tools using proprietary ultra-high-throughput wet-lab screening plus ML. Public sources conflict slightly on founding year (YC says 2022; LinkedIn shows 2023), so the company appears to have launched in YC W23 and is headquartered in Watertown, MA. No public GitHub or X profile was found.
Primary product
Proprietary engineered enzymes, especially Phi29-like polymerases (Saiyan-Phi29, PD-Phi29) and custom enzyme-development services
Founded
2022
Headquarters
134 Coolidge Avenue, Watertown, Massachusetts 02472, United States
Team size
1-10
Work style
Onsite
Industry
Biotechnology Research
Sub-industry
Synthetic biology / enzyme engineering
Offices
134 Coolidge Avenue, Watertown, Massachusetts 02472, United States
Business model
catalog enzyme sales
custom enzyme R&D services
biocatalysis project services
bulk/distribution sales for enzymes
Funding
Stage
Pre-Seed
Total raised
$500K
Latest round
Pre-Seed · Apr 2023
Latest amount
$500K
Apr 2023 · Y Combinator
People & investors
Work & culture
Hands-on, science-heavy, fast-paced, and collaborative; the team blends wet-lab scientists and machine-learning engineers and emphasizes rapid enzyme discovery and validation.
Work style
Onsite
Product & market
Pricing
Quote-based B2B pricing for custom R&D projects plus direct sale/distribution of proprietary enzymes; no public pricing found.
Differentiators
- —proprietary PDTM wet-lab + AI platform
- —ultra-high-throughput droplet screening
- —claims 1,000x more enzymes screened than traditional methods
- —faster and cheaper screening cycle
- —FTO/no prior-art focus
- —validated orthogonal readouts before release
- —catalog products plus custom services
Technology
droplet-based ultra-high-throughput screening
machine learning models
design-build-test-learn workflow
sequencing-based genotype/function readout
plate-reader kinetics
HPLC
SDS-PAGE
Agilent TapeStation
Qubit BR
Oxford Nanopore
PCR
automation
Customers
pharma companies
diagnostic companies
biotech companies
recurring pharma clients
molecular diagnostics customers
life science tools buyers
Competitors
Codexis
Ginkgo Bioworks
Allozymes
Biomatter
Eucodis Bioscience
Scale & contact
Estimated revenue
about $1M ARR (2024 estimate)
Estimated monthly visits
1.1K
Traffic estimate as of Feb 2025
Jobs and careers at Pando Bioscience
0 jobs at Pando Bioscience
No open positions
Check back later for new openings